Impact of Neurostimulation on Patterns of Brain Electrical Activity in Patients With Tinnitus
NCT ID: NCT03036137
Last Updated: 2017-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
54 participants
INTERVENTIONAL
2017-02-01
2017-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuromodulation Techniques in the Treatment of Chronic Tinnitus With Hearing Loss
NCT01944501
Long-term tDCS Tinnitus Treatment
NCT05437185
rTMS Bimodal Treatment For Tinnitus: A Pilot Study
NCT01590264
Comparison Between Transcranial Stimulation Protocols With Continuous Current in the Chronic Migraine
NCT03414203
Transcranial Direct Current Stimulation (tDCS) for the Treatment of Tinnitus
NCT01575496
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active tDCS
Subjects will receive 20 minutes of active tDCS for five consecutive days, current of 2 mA, in the temporoparietal left area, and right prefrontal cortex.
Transcranial Direct Current Stimulation
Anodal stimulation of the temporoparietal left area with an cathode over the right dorsolateral prefrontal cortex. Stimulation will be applied for 20 minutes at 2 mA.
Sham tDCS
Subjects will receive 20 minutes of Sham tDCS for five consecutive days in the temporoparietal left area, and right prefrontal cortex.
Sham Transcranial Direct Current Stimulation
Sham tDCS sessions will last 20 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial Direct Current Stimulation
Anodal stimulation of the temporoparietal left area with an cathode over the right dorsolateral prefrontal cortex. Stimulation will be applied for 20 minutes at 2 mA.
Sham Transcranial Direct Current Stimulation
Sham tDCS sessions will last 20 minutes
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic tinnitus for at least 6 months.
* Age-adjusted normal (sensorineural) hearing
Exclusion Criteria
* Concurrent treatment for tinnitus;
* Prior exposure to transcranial direct current stimulation (tDCS);
* History of epilepsy and/or seizures;
* Electronic implants or metallic objects in body;
* Skin conditions where electrodes will be applied;
* Major neurological co-morbidities.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Paraíba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dayse da Silva Souza
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dayse Souza
João Pessoa, Paraíba, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
61192416.9.0000.5188
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.